IndexIQ Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

IndexIQ Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-108,007	Closed	-$335K	–	1602
2021 Q4	$335K	Sell	108,007 -6,980	-6%	-$23.5K	0.01%	896
2021 Q3	$415K	Buy	114,987 +11,518	+11%	+$43.4K	0.01%	777
2021 Q2	$370K	Sell	103,469 -3,561	-3%	-$12.6K	0.01%	856
2021 Q1	$418K	Buy	+107,030	New	+$442K	0.01%	466

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

IndexIQ Advisors's BDSI Position: Q1 2022 in Review

IndexIQ Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 108,007 shares — an estimated $335K sold.

IndexIQ Advisors first reported a position in BDSI in Q1 2021 and held it in 4 quarters. The position peaked at $418K in Q1 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

IndexIQ Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
IndexIQ Advisors sold 108,007 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $335K.
IndexIQ Advisors first reported a position in BioDelivery Sciences International, Inc. in Q1 2021 and held it in 4 quarters.
IndexIQ Advisors's BioDelivery Sciences International, Inc. position peaked at $418K in Q1 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.